These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8773814)

  • 1. Relationship between insight, educational background and cognition in schizophrenia.
    Macpherson R; Jerrom B; Hughes A
    Br J Psychiatry; 1996 Jun; 168(6):718-22. PubMed ID: 8773814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociating self-reported cognitive complaint from clinical insight in schizophrenia.
    Bayard S; Capdevielle D; Boulenger JP; Raffard S
    Eur Psychiatry; 2009 May; 24(4):251-8. PubMed ID: 19324531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between insight and symptoms in schizophrenia.
    Sevy S; Nathanson K; Visweswaraiah H; Amador X
    Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.
    Gharabawi G; Bossie C; Turkoz I; Kujawa M; Mahmoud R; Simpson G
    J Nerv Ment Dis; 2007 Dec; 195(12):976-82. PubMed ID: 18091190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of education about drug treatment in schizophrenia.
    Macpherson R; Jerrom B; Hughes A
    Br J Psychiatry; 1996 Jun; 168(6):709-17. PubMed ID: 8773813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into neurocognitive dysfunction in schizophrenia.
    Medalia A; Thysen J
    Schizophr Bull; 2008 Nov; 34(6):1221-30. PubMed ID: 18199632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conceptualizing schizophrenia through attenuated symptoms in the population.
    Carpenter WT
    Am J Psychiatry; 2010 Sep; 167(9):1013-6. PubMed ID: 20826849
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data.
    Ozzoude M; Nakajima S; Plitman E; Chung JK; Kim J; Iwata Y; Caravaggio F; Takeuchi H; Uchida H; Graff-Guerrero A; Gerretsen P
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():207-213. PubMed ID: 30172739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight in schizophrenia. Its relationship to acute psychopathology.
    McEvoy JP; Apperson LJ; Appelbaum PS; Ortlip P; Brecosky J; Hammill K; Geller JL; Roth L
    J Nerv Ment Dis; 1989 Jan; 177(1):43-7. PubMed ID: 2562850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences on cognitive heterogeneity in schizophrenia.
    Goldstein G; Shemansky WJ
    Schizophr Res; 1995 Dec; 18(1):59-69. PubMed ID: 8929762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model].
    Raffard S; Bayard S; Capdevielle D; Garcia F; Boulenger JP; Gely-Nargeot MC
    Encephale; 2008 Dec; 34(6):597-605. PubMed ID: 19081457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness of illness in schizophrenia and outpatient treatment adherence.
    Cuffel BJ; Alford J; Fischer EP; Owen RR
    J Nerv Ment Dis; 1996 Nov; 184(11):653-9. PubMed ID: 8955677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
    Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intellectual functioning and the long-term course of schizophrenia-spectrum illness.
    Carter JW; Parnas J; Urfer-Parnas A; Watson J; Mednick SA
    Psychol Med; 2011 Jun; 41(6):1223-37. PubMed ID: 20860870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of insight in patients with schizophrenia and bipolar disorder in remission.
    Yen CF; Chen CS; Yeh ML; Yen JY; Ker JH; Yang SJ
    J Nerv Ment Dis; 2002 Dec; 190(12):847-9. PubMed ID: 12486373
    [No Abstract]   [Full Text] [Related]  

  • 19. A polydiagnostic approach to self-perceived cognitive disorders in schizophrenia.
    Peralta V; Cuesta MJ
    Psychopathology; 1992; 25(5):232-8. PubMed ID: 1293622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight dimensions and cognitive function in psychosis: a longitudinal study.
    Cuesta MJ; Peralta V; Zarzuela A; Zandio M
    BMC Psychiatry; 2006 May; 6():26. PubMed ID: 16737523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.